Vigilare Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Vigilare Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,513	Closed	-$279K	–	118
2022 Q3	$279K	Sell	4,513 -20	-0.4%	-$1.4K	0.36%	70
2022 Q2	$362K	Sell	4,533 -2,587	-36%	-$245K	0.39%	59
2022 Q1	$749K	Sell	7,120 -2,200	-24%	-$214K	0.61%	43
2021 Q4	$1M	Sell	9,320 -150	-2%	-$16.4K	0.59%	45
2021 Q3	$1.04M	Sell	9,470 -40	-0.4%	-$4.15K	0.64%	38
2021 Q2	$891K	Sell	9,510 -700	-7%	-$64.4K	0.54%	46
2021 Q1	$940K	Sell	10,210 -775	-7%	-$65.4K	0.67%	39
2020 Q4	$804K	Buy	10,985 +3,772	+52%	+$280K	0.76%	36
2020 Q3	$560K	Buy	7,213 +300	+4%	+$20.6K	0.58%	48
2020 Q2	$384K	Sell	6,913 -1,885	-21%	-$80.6K	0.39%	59
2020 Q1	$261K	Buy	+8,798	New	+$298K	0.31%	83

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vigilare Wealth Management's HZNP Position: Q4 2022 in Review

Vigilare Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 4,513 shares — an estimated $279K sold.

Vigilare Wealth Management first reported a position in HZNP in Q1 2020 and held it in 11 quarters. The position peaked at $1.04M in Q3 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Vigilare Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Vigilare Wealth Management sold 4,513 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $279K.
Vigilare Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2020 and held it in 11 quarters.
Vigilare Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.04M in Q3 2021.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Vigilare Wealth Management's 13F filing for Q4 2022, filed 11 Jan 2023.